Roivant Sciences Ltd.
ROIV
$11.92
$0.110.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -334.38% | -36.63% | -96.68% | -- | 132.66% |
| Total Depreciation and Amortization | -46.41% | -40.81% | -22.87% | -- | -64.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 126.28% | -167.69% | 93.89% | -- | -359.16% |
| Change in Net Operating Assets | 54.20% | 116.13% | -350.55% | -- | -81.34% |
| Cash from Operations | -5.99% | -59.11% | 1.52% | -- | 22.85% |
| Capital Expenditure | -318.13% | -132.38% | -414.65% | -- | -139.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 9,419.15% | -97.05% | -- | -- |
| Other Investing Activities | -- | 12,275.68% | -- | -- | -- |
| Cash from Investing | -112,409.43% | 15,405.11% | -91.32% | -- | -1,019.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -540.71% | -- | 76.58% |
| Issuance of Common Stock | 1,223.51% | 254.88% | 216.57% | -- | -89.20% |
| Repurchase of Common Stock | 67.05% | -958.59% | -7,505.64% | -- | -11,410.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 71.58% | -443.01% | -215.34% | -- | -8,935.31% |
| Foreign Exchange rate Adjustments | 129.74% | 42.81% | -135.08% | -- | -2,241.88% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -72.32% | 636.25% | -100.52% | -- | -253.51% |